A critical update has emerged in the investigation surrounding the deaths of five women following childbirth at the New Medical College Hospital in Kota. Authorities have discovered that a batch of the medication Dynoprostone Gel, used during the delivery process, failed quality control standards. Following this finding, the Drug Control Department has issued an immediate ban on the sale and distribution of this specific batch across Rajasthan. While the investigation remains ongoing, officials have not yet officially concluded that this medication was the direct cause of the fatalities.
Batch H-084 Fails Laboratory Testing
The investigation into the medical supplies began on May 17, when the Drug Control Department collected samples of Dynoprostone Gel, specifically batch number H-084, from the New Medical College Hospital in Kota. These samples were forwarded to the State Drug Testing Laboratory in Jaipur for analysis. The laboratory report confirmed that the batch did not meet the required quality standards. Upon receiving these results, the department initiated immediate enforcement actions, ordering the recall of this batch from all hospitals and distribution centers across the state.
Seizure of 1117 Packets and Legal Action
In a significant operation, the Drug Control Department seized 1117 packets of the affected batch from the MCDW store located in Nayapura, Kota. Departmental officials have confirmed that statutory legal proceedings have been initiated against the manufacturing company under the provisions of the Drugs and Cosmetics Act. Furthermore, authorities are currently tracing the distribution network to identify every hospital and healthcare institution that received supplies from this specific batch to ensure that no further usage occurs.
Case Highlights Safety Concerns
The tragedy gained widespread attention after five women died in the New Medical College Hospital following their labor procedures. These deaths prompted the health department to initiate a thorough probe into the hospital's operations. The investigation initially focused on multiple aspects, including medical procedures, the quality of drugs, potential infections, adherence to clinical protocols, and general hospital management. The state government had previously constituted an expert team to conduct a comprehensive inquiry and requested a detailed report from the hospital administration regarding the sequence of events.
Usage of Dynoprostone Gel in Obstetrics
It was revealed during the investigation that the women who passed away had been administered Dynoprostone Gel from the faulty batch H-084 during their delivery process. This medication is widely utilized in obstetrics to induce labor and prepare the cervix for childbirth. Given its routine use in maternity care, the failure of a specific batch in quality testing is being viewed as a matter of serious concern for the healthcare system.
Awaiting Final Investigation Findings
Currently, the health department and the Drug Control Department are conducting investigations at various levels. Officials stated that a definitive conclusion regarding whether there is a direct link between the quality of the medication and the deaths of the women will only be established once the full investigation is completed. The authorities have promised that if the inquiry confirms any negligence or violation of regulations, strict action will be taken against the individuals involved and the manufacturing company in accordance with the law.
